Starting Dose of Prazosin for Nightmares
Begin prazosin at 1 mg at bedtime, then increase by 1-2 mg every few days until an effective dose is reached, typically 3-15 mg nightly for most patients. 1
Initial Dosing Protocol
The American Academy of Sleep Medicine guidelines consistently recommend:
- Start: 1 mg at bedtime (never start with 2 mg or 5 mg capsules)
- Titration: Increase by 1-2 mg every few days based on nightmare response and tolerability
- Target maintenance: 3-6 mg nightly for most civilian patients 1
The FDA label explicitly warns that patients must always be started on 1 mg capsules, as the 2 mg and 5 mg capsules are not indicated for initial therapy due to syncope risk (approximately 1% with initial doses ≥2 mg) 2.
Maintenance Dosing Ranges
Civilian trauma patients: Average effective dose is approximately 3 mg nightly (range 1-10 mg) 1
Military/combat veterans: Higher doses are often required:
- Men: Mean 15.6 ± 6.0 mg at bedtime
- Women: Mean 7.0 ± 3.5 mg at bedtime 3
Studies show effective doses ranging from 1 mg to over 20 mg daily, with most therapeutic benefit occurring between 6-15 mg in divided or single bedtime doses 3.
Critical Safety Monitoring
First-dose hypotension is the primary concern. Monitor blood pressure after the initial 1 mg dose, as syncopal episodes typically occur within 30-90 minutes of the first dose 2. The slow titration schedule minimizes this risk while allowing identification of the minimum effective dose for each patient.
Monitor for:
- Orthostatic hypotension (most common adverse effect)
- Dizziness and lightheadedness
- Syncope (rare with proper dosing)
- Priapism (rare but requires immediate attention if >4 hours) 2
Important Clinical Nuances
Antidepressant interaction: There appears to be reduced prazosin efficacy in patients taking concurrent SSRIs. In one study, CAPS scores decreased by 30.1 ± 3.8 in patients not on SSRIs versus only 9.6 ± 6.8 in those taking SSRIs 3. Consider this when setting expectations, though prazosin remains first-line pharmacotherapy even with concurrent antidepressants.
Evidence quality caveat: While the 2010 AASM guidelines gave prazosin a Level A recommendation, the 2018 position paper downgraded this after a large VA study (n=304) showed no benefit at mean doses of 14.8 mg over 26 weeks 3. However, clinicians observe that many patients respond very well, and prazosin remains the first-choice pharmacologic agent for nightmare disorder 3.
Timing of benefit: When effective, nightmare reduction typically occurs within 1 week of reaching therapeutic dose 4, 5.
Practical Titration Example
- Week 1: 1 mg at bedtime
- Week 2: 2 mg at bedtime (if tolerated)
- Week 3: 3-4 mg at bedtime (if tolerated)
- Week 4+: Continue increasing by 1-2 mg every few days until nightmares improve or side effects limit further increases
Stop titration when adequate nightmare control is achieved. Most civilian patients respond to 3-6 mg, but some require higher doses similar to those used in military populations 1.